Android app on Google Play

Roth Capital Starts Endocyte (ECYT) at Buy

February 15, 2013 7:28 AM EST Send to a Friend
Get Alerts ECYT Hot Sheet
Price: $6.66 -3.2%

Rating Summary:
    8 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 13 | New: 28
Trade ECYT Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Endocyte (NASDAQ: ECYT) with a Buy. PT $15.00.

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $9.43 yesterday.

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment